Association of quantified cardiovascular health status with all-cause mortality risk in prediabetic patients.

IF 4.6 3区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Ao-Miao Chen, Qiu-Yu He, Yi-Chuan Wu, Jia-Qi Chen, Xiao-Qin Ma, Ling-Yuan Hu, Ge-Ning-Yue Wang, Zhuo-Tong Wang, Zhi-Yong Wu, Zong-Ji Zheng, Yi-Jie Jia
{"title":"Association of quantified cardiovascular health status with all-cause mortality risk in prediabetic patients.","authors":"Ao-Miao Chen, Qiu-Yu He, Yi-Chuan Wu, Jia-Qi Chen, Xiao-Qin Ma, Ling-Yuan Hu, Ge-Ning-Yue Wang, Zhuo-Tong Wang, Zhi-Yong Wu, Zong-Ji Zheng, Yi-Jie Jia","doi":"10.4239/wjd.v16.i5.102052","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with prediabetes are at increased risk of developing cardiovascular disease. The Life's Essential 8 (LE8) score, updated by the American Heart Association in 2022, is a tool used to quantify cardiovascular health (CVH). Quantifying healthy living status on the basis of the uniform standard LE8 will be useful for confirming whether health interventions can reduce the risk of death in prediabetic patients.</p><p><strong>Aim: </strong>To investigate the associations between all-cause mortality risk and CVH status (as quantified by the LE8 score) in prediabetic patients.</p><p><strong>Methods: </strong>This study included 5344 participants with prediabetes (age: 52.9 ± 15.8 years; 51.6% men). The LE8 score includes four health indicators and four health behaviors. Cox proportional hazard ratios were calculated for all-cause mortality in the high CVH (LE8 ≥ 80), low CVH (LE8 ≤ 50), and moderate CVH (LE8 50-79) subgroups, and restricted cubic spline analyses were performed. Separate analyses of the associations of all-cause mortality risk with each LE8 component and CVH health behaviors and indicators were also performed.</p><p><strong>Results: </strong>In the median follow-up period of 8.33 years, 658 deaths occurred. Compared with those among participants with high CVH, the covariate-adjusted HRs (95% confidence intervals) for mortality among participants with moderate and low CVH were 2.55 (1.23-5.31) and 3.92 (1.70-9.02), respectively. There was a linear relationship between an improvement in CVH status and a reduction in all-cause mortality risk (<i>P</i>-overall < 0.0001, <i>P</i>-nonlinear = 0.7989). Improved CVH health behaviors had a more significant protective effect on patients with prediabetes than did the improvement in CVH health indicators.</p><p><strong>Conclusion: </strong>High CVH status (as quantified by the LE8 score) is significantly associated with reduced mortality risk in prediabetic adults in the United States.</p>","PeriodicalId":48607,"journal":{"name":"World Journal of Diabetes","volume":"16 5","pages":"102052"},"PeriodicalIF":4.6000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12142195/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Diabetes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4239/wjd.v16.i5.102052","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Patients with prediabetes are at increased risk of developing cardiovascular disease. The Life's Essential 8 (LE8) score, updated by the American Heart Association in 2022, is a tool used to quantify cardiovascular health (CVH). Quantifying healthy living status on the basis of the uniform standard LE8 will be useful for confirming whether health interventions can reduce the risk of death in prediabetic patients.

Aim: To investigate the associations between all-cause mortality risk and CVH status (as quantified by the LE8 score) in prediabetic patients.

Methods: This study included 5344 participants with prediabetes (age: 52.9 ± 15.8 years; 51.6% men). The LE8 score includes four health indicators and four health behaviors. Cox proportional hazard ratios were calculated for all-cause mortality in the high CVH (LE8 ≥ 80), low CVH (LE8 ≤ 50), and moderate CVH (LE8 50-79) subgroups, and restricted cubic spline analyses were performed. Separate analyses of the associations of all-cause mortality risk with each LE8 component and CVH health behaviors and indicators were also performed.

Results: In the median follow-up period of 8.33 years, 658 deaths occurred. Compared with those among participants with high CVH, the covariate-adjusted HRs (95% confidence intervals) for mortality among participants with moderate and low CVH were 2.55 (1.23-5.31) and 3.92 (1.70-9.02), respectively. There was a linear relationship between an improvement in CVH status and a reduction in all-cause mortality risk (P-overall < 0.0001, P-nonlinear = 0.7989). Improved CVH health behaviors had a more significant protective effect on patients with prediabetes than did the improvement in CVH health indicators.

Conclusion: High CVH status (as quantified by the LE8 score) is significantly associated with reduced mortality risk in prediabetic adults in the United States.

量化心血管健康状况与糖尿病前期患者全因死亡风险的关系
背景:糖尿病前期患者发生心血管疾病的风险增加。美国心脏协会于2022年更新了生命基本8 (LE8)评分,这是一种量化心血管健康(CVH)的工具。在LE8统一标准的基础上量化健康生活状态,将有助于确认健康干预是否能降低糖尿病前期患者的死亡风险。目的:探讨糖尿病前期患者全因死亡风险与CVH状态(由LE8评分量化)之间的关系。方法:本研究纳入5344例糖尿病前期患者(年龄:52.9±15.8岁;51.6%的男性)。LE8评分包括4项健康指标和4种健康行为。计算高CVH (LE8≥80)、低CVH (LE8≤50)和中度CVH (LE8 50-79)亚组全因死亡率的Cox比例风险比,并进行限制性三次样条分析。还对全因死亡风险与每个LE8成分和CVH健康行为和指标的关系进行了单独分析。结果:中位随访8.33年,死亡658例。与高CVH组相比,中低CVH组死亡率的协变量校正hr(95%置信区间)分别为2.55(1.23-5.31)和3.92(1.70-9.02)。CVH状态的改善与全因死亡风险的降低之间存在线性关系(P-overall < 0.0001, P-nonlinear = 0.7989)。改善CVH健康行为对糖尿病前期患者的保护作用比改善CVH健康指标更显著。结论:在美国,高CVH状态(由LE8评分量化)与糖尿病前期成人死亡风险降低显著相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World Journal of Diabetes
World Journal of Diabetes ENDOCRINOLOGY & METABOLISM-
自引率
2.40%
发文量
909
期刊介绍: The WJD is a high-quality, peer reviewed, open-access journal. The primary task of WJD is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of diabetes. In order to promote productive academic communication, the peer review process for the WJD is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJD are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in diabetes. Scope: Diabetes Complications, Experimental Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes, Gestational, Diabetic Angiopathies, Diabetic Cardiomyopathies, Diabetic Coma, Diabetic Ketoacidosis, Diabetic Nephropathies, Diabetic Neuropathies, Donohue Syndrome, Fetal Macrosomia, and Prediabetic State.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信